Valor202020212022202320242025TTMGastos comerciales, generales y administrativos1.23 B1.49 B1.57 B1.82 B1.79 B2.09 B2.09 BInvestigación y desarrollo760.7 M903.1 M945.2 M1.07 B1.05 B1.08 B1.08 BBeneficio operativo897.6 M1.69 B1.75 B1.53 B1.38 B1.26 B1.26 BTotal de ingresos no operativos46.8 M34.8 M-13.5 M93.2 M169.4 M8.7 M8.7 MGastos por intereses, netos de intereses capitalizados15.8 M18.4 M19.2 M17.6 M19.8 M20.4 M—Ingresos no operativos, una vez deducidos los gastos por intereses19.5 M3.7 M-35.3 M61.2 M80.7 M-18.9 M1.5 MIngresos/gastos extraordinarios11.5 M12.7 M2.6 M14.4 M68.9 M7.2 M7.2 MBeneficio antes de impuestos916.7 M1.7 B1.77 B1.6 B1.55 B1.27 B1.27 BParticipación en los beneficios———————Impuestos93.3 M198.9 M245.5 M198.7 M152.1 M216.9 M216.9 MParticipación minoritaria———-3 M-4.9 M-4.1 M-4.1 MOtros ingresos/gastos después de impuestos3.5 M23.4 M-7.8 M-8.4 M-18.4 M-7.7 M-7.7 MBeneficio neto antes de actividades interrumpidas823.4 M1.5 B1.52 B1.4 B1.4 B1.06 B1.06 BOperaciones suspendidas————2.77 B13.4 M13.4 MBeneficio neto823.4 M1.5 B1.52 B1.4 B4.17 B1.07 B1.07 BAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas823.4 M1.5 B1.52 B1.4 B4.17 B1.07 B1.07 BBeneficio básico por acción1.322.412.462.316.981.841.84Beneficio por acción diluido1.32.382.442.36.971.831.83Número medio de acciones ordinarias622.6 M623.3 M619 M606.7 M597.7 M584.8 M2.34 BAcciones diluidas631.9 M631.2 M624.2 M609.4 M599.3 M585.8 M2.35 BEBITDA1.01 B1.69 B1.85 B1.87 B4.86 B1.21 B1.27 BEBIT905.8 M1.56 B1.71 B1.72 B4.7 B1.05 B1.11 BCosto de los ingresos1.08 B1.25 B1.08 B1.38 B1.12 B1.33 B1.33 BOtros costes de producción00—————Amortización y depreciación (flujo de caja)107.2 M134.8 M139.6 M144.9 M155.2 M156.6 M156.6 M
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility completed in 2021 in Limerick, Ireland.